Jon Epstein Lab

still don’t think I’ve fully processed the last few days but i got a PhD, isn’t that wild so much gratitude in my heart for everyone who has been a part of the ride, and esp @jonepstein1 who shaped me into the scientist that i am today and for many years of mentorship and care

Congratulations to Faith Karanja (@JonEpsteinLab/ @PennCDB) & Jeffrey Rosa (@KayserLab/ @PennPsych) on being named 2023 @LSRFdtn early-career postdoctoral researcher awardees!🎉 @PennBPP t.ly/xqU3X

Graduate student @DevBioAcademic defends his thesis 3 weeks from today! Contact him for the zoom link if you'd like to attend remotely. @CAMBUpenn

Great talk by Dr. Jon Epstein on In Vivo CAR T Cells for Cardiac Fibrosis during Day 2 of the Symposium! @StanfordCVI @PennMedEVDCSO @jonepstein1

Winners of Poster Award Competition @PennCVI @stanfordcvi symposium from @Prosser_Lab @jonepstein1 and @MarguliesLab . Congratulations!!

Last session of the @PennCVI / @StanfordCVI symposium starting with @jonepstein1 @JonEpsteinLab

@aimeejuan3 epic thesis work is out--a new developmentally unveiled and allele-specific CTCF insulator & DMR regulates imprinted expression of Grb10 and Ddc isoforms in mesoderm. TY collaborators @JonEpsteinLab @DevBioAcademic authors.elsevier.com/a/1flS93vVUPK8…

Hey Everyone! The ModzLab has room for one more PostDoc! We have a few exciting projects that look at Retrotransposons in Development and Disease, with a bit of CRISPR sprinkled here and there. Please Re-Tweet! Post Doctoral Researcher jobs.sciencecareers.org/job/612781/pos…

We continue to explore how heterochromatin is organized at the nuclear periphery! Check out our new exciting work available on @biorxivpreprint. PRR14 organizes H3K9me3-modifed heterochromatin at the nuclear lamina biorxiv.org/content/10.110…

#sciencesunday Fighting cardiac fibrosis🔥🫀@DevBioAcademic and colleagues used mRNA containing lipid nanoparticles to generate CAR T cells in vivo, reducing fibrosis & restoring cardiac function. Published in @ScienceMagazine @JonEpsteinLab @YoungDgk science.org/doi/10.1126/sc…

Today we celebrate Ricardo Linares-Saldana from the Epstein @JonEpsteinLab @jonepstein1 and Jain labs #BGSgraduation2022 1/9

Congrats to our rockstar postbac @PedroOMndezFer1 who was accepted into Penn's MD/PhD program this week, celebrating with tahini shakes from Goldie! We are soooo proud of you!!

Merging RNA technology and #cardioimmunology to tackle heart fibrosis - some thoughts from @McKinseyLab and us on this exciting new approach by @JonEpsteinLab & colleagues. Check out the full paper at science.org/doi/10.1126/sc… #CardioTwitter

“CAR-based therapies: opportunities for immuno-medicine beyond cancer” Haig Aghajanian (@Haig_A), Joel Rurik (@DevBioAcademic) and @JonEpsteinLab offer their perspective on this rapidly growing area: nature.com/articles/s4225…

Our lab (and BGS/CAMB) is full of great people! @JonEpsteinLab is interested broadly in heart development. Much of our lab (including fellow DSRB student, friend, & excellent human @karenwong1013) studies how gene programs are epigenetically regulated at the nuclear periphery.

Good morning! I’m Joel Rurik (@DevBioAcademic) delighted to do the first CAMB twitter takeover of 2022! As a 4th yr DSRB PhD candidate in @JonEpsteinLab, I study the injured heart and develop exciting mRNA-based immuno-medicine therapies.

In this week's @ScienceMagazine cover story, @DevBioAcademic, @Haig_Ag, @WeissmanLab, Parhiz, @JonEpsteinLab, & al. use CD5-targeted lipid #nanoparticles to generate therapeutic #CARTcells in vivo! bit.ly/Sci_abm0594 w/ PS by Gao & Chen: bit.ly/Sci_abn0851

You may have missed this exciting report @ScienceMagazine for the potential of mRNA/nanoparticle -> engineer T cells to treat cardiac injury, heart failure and other fibrotic disorders science.org/doi/10.1126/sc… @JonEpsteinLab @ScienceVisuals @cbickel27